Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.

@article{Harro2004RecruitmentAB,
  title={Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.},
  author={Clayton D Harro and Franklyn N. Judson and Geoffrey J Gorse and Kenneth H. Mayer and Jay R. Kostman and Stephen J. Brown and Beryl A Koblin and Michael J Marmor and Bradford Noyes Bartholow and Vladimir M. Popovic},
  journal={Journal of acquired immune deficiency syndromes},
  year={2004},
  volume={37 3},
  pages={1385-92}
}
OBJECTIVE To describe recruitment and baseline epidemiologic characteristics of volunteers in the first phase 3 placebo-controlled trial of a recombinant gp120 HIV vaccine (AIDSVAX B/B). METHODS Volunteers were gay/bisexual men or women at risk for sexually transmitted HIV infection. Recruitment strategies, demographics, and risk factors were assessed. HIV status was determined by standard HIV-1 antibody assays. Seronegative/viremic HIV infection at enrollment was determined using the HIV-1… CONTINUE READING